Melpor (Meloxicam)

Meloxicam blocks the activity of cyclooxygenase enzymes COX‑1 and COX‑2, especially COX‑2, which are needed to convert arachidonic acid into prostaglandins. By lowering prostaglandin production at sites of inflammation, the drug diminishes pain, swelling, and fever while preserving some gastric protection compared with non‑selective NSAIDs.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the specific indication, patient age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of meloxicam during pregnancy and lactation has not been definitively established. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant, and it should be prescribed only after careful consideration by a qualified clinician.

To request Melpor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Meloxicam offers a longer half‑life and greater COX‑2 selectivity than many traditional NSAIDs, allowing once‑daily dosing for many patients and potentially lower gastrointestinal risk. However, it still shares class‑related risks such as cardiovascular and renal effects, so selection should be individualized based on patient comorbidities.

Melpor should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Melpor is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are often advised to take it with meals. Swallow the tablet whole; do not crush or chew it.

Serious adverse events include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, acute kidney injury, severe skin reactions (e.g., Stevens‑Johnson syndrome), and liver injury. Patients should seek immediate medical attention if they notice signs like black stools, chest pain, sudden swelling, rash, or jaundice.

Meloxicam is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, and patients who have had a recent coronary artery bypass graft. Caution is also required in patients with impaired renal or hepatic function.